Company attributes
Industry
B2X
CEO
Founder
Pitchbook URL
Date Incorporated
2009
Number of Employees (Ranges)
11 – 50
Full Address
18-20 rue Jacques Dulud 92200 Paris France
Founded Date
2009
0Total Funding Amount (USD)
16,500,000
Latest Funding Round Date
May 2014
Competitors
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Established in 2009, Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
